| NCT ID | NCT05147948 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Skane University Hospital |
| Condition | Ptsd |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2021-10-18 |
| Primary Completion | 2026-10-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2021-10-18 with a primary completion date of 2026-10-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for PTSD and comorbid chronic pain using a randomized controlled trial with waitlist control.
Eligibility Criteria
Inclusion Criteria: * a CAPS of ≥25 * subjected to single traumatic events * were able to understand Swedish * had symptoms of chronic pain that interfered significantly with everyday life * were fully examined medically and had received medical treatment if indicated * were able to be an active part of the rehabilitation process, regain functioning in different life areas and participate in treatment interventions for approximately 5 hours every week * stable dose of medication * able to read and write in Swedish * had access to a smart phone or computer with internet access Exclusion Criteria: * repeated and extensive traumatic events * had other acute or severe psychiatric disorders or symptoms that warranted designation as the primary disorder (ongoing substance dependence, untreated bipolar disorder, OCD, psychotic symptoms, severe depression) * were actively abusing analgesic medications (including narcotics), alcohol or other drugs * had great difficulty to harbour and handle strong emotions that could lead to emotional outbursts or self-harming behavior * had health risks due to medical reasons * had social or economic difficulties or lack of social support that hindered behavior change * current severe suicidal ideation that warranted immediate intervention (indicated by the MINI and a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9))
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05147948 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Ptsd. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05147948 currently recruiting?
Yes, NCT05147948 is actively recruiting participants. Contact the research team at Sophia.akerblom@psy.lu.se for enrollment information.
Where is the NCT05147948 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT05147948 clinical trial?
NCT05147948 is sponsored by Skane University Hospital. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.